跳至主要内容
临床试验/EUCTR2005-000715-98-IT
EUCTR2005-000715-98-IT进行中(未招募)不适用

A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patients with Atrial fibrillation/atrial flutter (AF/AFL)

SANOFI-SYNTHELABO0 个研究点目标入组 3,700 人开始时间: 2005年11月4日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
3,700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

相似试验

进行中(未招募)
不适用
A placebo-controlled, double blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter (AF/AFL) - ATHENAatrial fibrillation/atrial flutterMedDRA version: 7.1Level: LLTClassification code 10003658
EUCTR2005-000715-98-DESanofi-Synthelabo Recherche3,700
进行中(未招募)
不适用
A placebo-controlled, double blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter (AF/AFL) - ATHENAatrial fibrillation/atrial flutterMedDRA version: 7.1Level: LLTClassification code 10003658
EUCTR2005-000715-98-CZsanofi-aventis recherche & développement4,300
进行中(未招募)
不适用
A placebo-controlled, double blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter (AF/AFL) - ATHENA
EUCTR2005-000715-98-PTSanofi-Synthelabo Recherche3,700
进行中(未招募)
不适用
A placebo-controlled, double blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter (AF/AFL) - ATHENAatrial fibrillation/atrial flutterMedDRA version: 7.1Level: LLTClassification code 10003658
EUCTR2005-000715-98-SEsanofi-aventis recherche & développement4,300
进行中(未招募)
1 期
A placebo-controlled, double blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter (AF/AFL) - ATHENA
EUCTR2005-000715-98-NOsanofi-aventis recherche & développement4,300